Latest papers

Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.

Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells.

Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer.

Immunotherapy of melanoma by GPI-anchored IL-21 tumour vaccine involves down-regulating regulatory T cells in mouse model.

Humoral immune response induced by an engineered cell-based neuroblastoma vaccine with or without CD25 blockade.

Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ.

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

Pilot study of 1650-G: a simplified cellular vaccine for lung cancer.

Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.

Current immunotherapeutic approaches in pancreatic cancer.

Molecular basis of applied biological therapeutics.

[The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].

Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm.

Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.

The inhibition of the T-cell immunoglobulin and mucin domain 3 (Tim3) pathway enhances the efficacy of tumor vaccine

Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data.

Renal cell cancer: state of the art in adjuvant therapy.

Designing Vaccines Based on Biology of Human Dendritic Cell Subsets

Vaccination against the extra domain-B of fibronectin as a novel tumor therapy.

The role of complement in dendritic cell (DC) control of T-cell subsets.